4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001827672-23-000002
President/CEO and Board Chair sold 1,634 shares at an average $15.16 ($24,773)
From the SEC's structured data for this filing
Trades in this filing
Azamian Bobak R. · President/CEO and Board Chair
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-09 | Sale : show line 1 in the form | −729 | $15.15 | $11,044 | 1,129,422 | I |
| 2023-01-10 | Sale : show line 2 in the form | −905 | $15.17 | $13,729 | 1,128,517 | I |
| Open-market sales · 1,634 sh · avg $15.16 · $24,773 | ||||||
Loading xslF345X03/wf-form4_167348676340762.xml…